At Sports Technology Labs, our Tesamorelin peptide is manufactured under strict quality control measures to ensure the highest level of purity and reliability. Each batch is tested for purity exceeding 98% and is accompanied by a Certificate of Analysis (COA) from accredited US laboratories, ensuring product integrity for research purposes. It is essential to consult a health care professional when learning about this product, as Tesamorelin is not approved for human consumption and is considered a research chemical.
Tesamorelin is a growth hormone-releasing hormone analogue used primarily for reducing visceral fat. Tesamorelin is used in clinical trials to manage HIV-associated lipodystrophy. It has shown significant benefits in patients infected with the human immunodeficiency virus (HIV), particularly in controlling fat accumulation and improving metabolic profiles.
FAQs for Tesamorelin Peptide
Tesamorelin is used in research to study its effects on growth hormone levels, body composition, fat metabolism, and various metabolic pathways.
Research also focuses on how Tesamorelin affects excess abdominal fat in HIV-infected patients experiencing lipodystrophy.
The purity of Tesamorelin is verified through high-performance liquid chromatography (HPLC) testing conducted by accredited US laboratories. Each batch is accompanied by a Certificate of Analysis (COA).
Tesamorelin should be stored in a cool, dry place away from direct sunlight. For optimal stability, long-term storage at -20°C is recommended.
Tesamorelin is packaged in a glass vial with a secure seal to prevent contamination. It is shipped in tamper-proof packaging to ensure safety and integrity during transit.
With over 98% purity, trust Sports Technology Labs for your next research project. Buy Tesamorelin Peptide now!
Why Choose Sports Technology Labs?
Premium Quality: All peptides undergo rigorous testing, including high-performance liquid chromatography (HPLC), to ensure the highest purity and quality standards.
Reliable Shipping: Our products are shipped in tamper-proof packaging and on ice to preserve integrity during transit.
Expert Support: Our knowledgeable team is available to assist with inquiries and help select the right peptides for your research needs.
Explore our extensive range of high-quality peptides and buy Tesamorelin today for your research purposes.
Additional information
Weight
0.25 oz
Dimensions
2 × 1 × 1 in
Tesamorelin
All Sports Technology Labs peptides are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. While not bottled in the USA, every batch is tested here to verify accuracy and purity. Our Certificates of Analysis confirm that products meet the listed specifications.
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that has been extensively studied for its effects on endogenous growth hormone levels. Researchers investigate its potential impact on fat metabolism, body composition, and various metabolic processes.
It works by stimulating the pituitary gland to release growth hormone. This, in turn, increases the production of insulin-like growth factor-1 (IGF-1), a crucial element in regulating body composition. IGF-1 helps in reducing excess abdominal fat and plays a significant role in overall body composition.
Mechanism of Action
Tesamorelin offers several areas of study, particularly for HIV-infected patients dealing with lipodystrophy. It is being studied for its effects on:
Excess Abdominal Fat
Body Composition
Insulin Sensitivity
IGF-1 Levels
The mechanism of action of Tesamorelin involves its binding to GHRH receptors in the pituitary gland, which stimulates the release of growth hormone. This growth hormone then prompts the liver to produce IGF-1, which mediates the effects of growth hormone on body composition.
It’s important to note that Tesamorelin is not a weight loss medication and should only be used under the guidance of a healthcare professional. Potential side effects include injection site reactions, joint pain, and changes in blood sugar levels. Patients should be closely monitored for these side effects.
For individuals with a history of pituitary gland tumor, stomach surgery, or glucose intolerance, Tesamorelin should be used with caution. Additionally, patients should be aware of the potential risk of trouble breathing and seek medical attention immediately if they experience any difficulty breathing.
Overall, Tesamorelin is a valuable treatment option for HIV-infected patients with lipodystrophy, offering a unique mechanism of action that targets the underlying causes of excess abdominal fat.
Data on Our Tesamorelin For Sale
CAS Number: 901758-09-6
Formula: C222H370N72O69S
Molar Mass: 5195.908 g/mol
Class: Growth hormone-releasing hormone snalog
Storage: Store in a cool, dry place away from direct sunlight to maximize shelf life. For long-term storage, it is recommended to keep the lyophilized peptide refrigerated at -20°C.
Tesamorelin: Tesamorelin should be stored in a cool, dry place and administered according to medical and research guidelines.
About This Product
Lyophilized sample in a sterile glass vial
2 mg Tesamorelin per vial
Glass vial with a secure seal to prevent contamination
Greater than 98% purity confirmed by analytical HPLC testing
Lab supplies and dilution solutions are not included. It is recommended to reconstitute this with 0.6% acetic acid.
Soluble in bacteriostatic water and compatible buffers for research applications
SKU: 56
Abuse Warning
Intended Use: This preparation is for laboratory research purposes only and is not approved by the FDA for human consumption. Tesamorelin is NOT a dietary or sports supplement.
Scientific References:
1. Dhillon, S. (2011). Spotlight on tesamorelin in HIV-associated lipodystrophy.BioDrugs,25(6), 405-408.
2. Stanley, T. L., Feldpausch, M. N., Oh, J., Branch, K. L., Lee, H., Torriani, M., & Grinspoon, S. K. (2014). Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. Jama, 312(4), 380-389.
3. Stanley, T. L., Fourman, L. T., Feldpausch, M. N., Purdy, J., Zheng, I., Pan, C. S., … & Grinspoon, S. K. (2019). Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. The Lancet HIV, 6(12), e821-e830.
4. Granata, R., Leone, S., Zhang, X., Gesmundo, I., Steenblock, C., Cai, R., … & Schally, A. V. (2024). Growth hormone-releasing hormone and its analogues in health and disease. Nature Reviews Endocrinology, 1-16.
6. Falutz, J., Potvin, D., Mamputu, J. C., Assaad, H., Zoltowska, M., Michaud, S. E., … & Grinspoon, S. (2010). Effects of Tesamorelin, a Growth Hormone–Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension. JAIDS Journal of Acquired Immune Deficiency Syndromes, 53(3), 311-322.
